Prognostic Impact of Lymph Node Ratio in Patients With Gastric Cancer Undergoing Curative Gastrectomy Post Neoadjuvant Chemotherapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background/Aim: The lymph node ratio (LNR), defined as the ratio of metastatic to examined lymph nodes, is a prognostic indicator in gastric cancer after curative gastrectomy. However, in response to neoadjuvant chemotherapy (NAC), the absolute number of metastatic lymph nodes may decrease. Moreover, the N-stage classification after this (ypN) alone may not fully reflect residual nodal disease. We evaluated whether LNR-based stratification offers improved prognostic discrimination compared with ypN classification, using survival analysis together with time-dependent receiver operating characteristics analysis. Patients and Methods: We retrospectively analyzed 201 patients with gastric adenocarcinoma who underwent post-NAC curative (R0) gastrectomy with D2 lymphadenectomy at Kanagawa Cancer Center (March 1992 to November 2019). Patients were classified using commonly reported LNR cutoffs: low (0.25). Recurrence-free (RFS) and overall survival (OS) were evaluated. The prognostic performance of the LNR and the ypN classification was compared using multivariate Cox proportional hazards models. Results: The median follow-up period was 37.6 months. Higher LNR was associated with worse RFS and OS (p
Fields of Study & Subjects
Gastric Cancer Management and Outcomes
Inflammatory Biomarkers in Disease Prognosis
Pancreatic and Hepatic Oncology Research
Publication details
- Journal / source
- Anticancer Research
- Volume
- 46
- Issue
- 4
- Pages
- 2239–2247
- Publication date
- 27 March 2026
- Language
- EN